Back to search results

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

Alzheimer Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Peking University Third Hospital, Beijing, China

    Contact: Principal Investigator (Qiong Yang)

  • The First Hospital of Jilin University, Changchun, China

    Study coordinator · 13504313689
    Contact: Principal Investigator (Li Sun)

  • Xiangya Hospital Central South University, Changsha, China

    Study coordinator · 073189753041
    Contact: Principal Investigator (Lu Shen)

  • Sichuan Provincial People's Hospital, Chengdu, China

    Contact: Principal Investigator (Nengwei Yu)

  • 2nd Affiliated Hospital Chongqing Medical University, Chongqing, China

    Study coordinator · +86 13032327639
    Contact: Principal Investigator (Xiaofeng Li)

  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    Study coordinator · +86 13618236535
    Contact: Principal Investigator (Yang Lv)

  • Fujian Medical University Union Hospital, Fuzhou, China

    Study coordinator · 18149568903
    Contact: Principal Investigator (Jiawei Xin)

  • Guangdong Provincial People's Hospital, Guangzhou, China

    Contact: Principal Investigator (jiehao zhao)

  • Anhui Provincial Hospital, Hefei, China

    Contact: Principal Investigator (Zhaozhao Cheng)

  • The Second Hospital of Jiaxing, Jiaxing, China

    Contact: Principal Investigator (Yanping Wang)

  • Jinan Central Hospital, Jinan, China

    Study coordinator · 15318816109
    Contact: Principal Investigator (Hong Bian)

  • The Second Affiliated Hospital of Nanchang University, Nanchang, China

    Contact: Principal Investigator (Zhenyu Tang)

  • Jiangsu Province Official Hospital, Nanjing, China

    Contact: Principal Investigator (Kezhong Zhang)

  • Nanjing Brain Hospital, Nanjing, China

    Study coordinator · 13372003816
    Contact: Principal Investigator (Weiwei Jiang)

  • Sir Run Run Hospital of Nanjing Medical University, Nanjing, China

    Contact: Principal Investigator (Xiang Lu)

  • The First Affiliated Hospital of Nanyang Medical College, Nanyang, China

    Contact: Principal Investigator (Qian Deng)

  • Shanghai Sixth People's Hospital, Shanghai, China

    Study coordinator · 02124056429
    Contact: Principal Investigator (Qihao Guo)

  • Shanghai East Hospital, Shanghai, China

    Contact: Principal Investigator (You Yin)

  • Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Contact: Principal Investigator (Gang Wang)

  • Huashan Hospital, Fudan University, Shanghai, China

    Study coordinator · 021-111111
    Contact: Principal Investigator (Jintai Yu)

  • Pudong New Area People's Hospital Shanghai, Shanghai, China

    Study coordinator · 021-20509000
    Contact: Principal Investigator (Xiaohui Zhao)

  • ShenZhen People's Hospital, Shenzhen, China

    Study coordinator · +86 13662205122
    Contact: Principal Investigator (Liangyu Zou)

  • The First Hospital of Hebei Medical University, Shijiazhuang, China

    Study coordinator · 0311-87155010
    Contact: Principal Investigator (Xiaowei Ma)

  • Tianjin Medical University General Hospital, Tianjin, China

    Study coordinator · 022-6036225
    Contact: Principal Investigator (Li Yang)

  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

    Contact: Principal Investigator (Zhen Wang)

  • Shaanxi provincial people's hospital, Xi'an, China

    Contact: Principal Investigator (Rui Li)

  • Xianyang Hospital of Yan'an University, Xianyang, China

    Study coordinator · 13572769709
    Contact: Principal Investigator (Aihong Guo)

  • Qinghai Provincial People's Hospital, Xining, China

    Contact: Principal Investigator (Xin Zhong)

  • Zigong First People's Hospital, Zigong, China

    Study coordinator · 15983171312
    Contact: Principal Investigator (Xiaoya Xu)

  • Zunyi First People's Hospital, Zunyi, China

    Contact: Principal Investigator (Fei Feng)
Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)